Overt diabetes mellitus in a patient with combined primary aldosteronism and Cushing's syndrome

Internal Medicine

Volumn 45, Issue 21, 2006, Pages 1237-1242

  Sasaki, Nobuhiro ^a   Iwase, Masanori ^a   Arima, Hisatomi ^a   Nohara, Sakae ^a   Bandai, Sachiko ^a   Yao, Takashi ^a   Fujii, Koji ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenal tumor; Cushing's syndrome; Hypertension; Insulin resistance; Insulin tolerance test

Indexed keywords

ALDOSTERONE; ATENOLOL; CADRALAZINE; DEXAMETHASONE; FUROSEMIDE; GLUCONATE POTASSIUM; GLUCOSE; HEMOGLOBIN A1C; HYDRALAZINE; HYDROCORTISONE; INSULIN; ISOPHANE INSULIN; NICARDIPINE; NIFEDIPINE; SPIRONOLACTONE; VERAPAMIL;

ADRENAL CORTEX ADENOMA; ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; BODY MASS; CASE REPORT; CLINICAL FEATURE; CUSHING SYNDROME; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LABORATORY TEST; PRIMARY HYPERALDOSTERONISM;

ADRENAL GLAND NEOPLASMS; CUSHING SYNDROME; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERALDOSTERONISM; MIDDLE AGED;

EID: 33845197745     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1855     Document Type: Article

References (20)

1. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202, 2004.
2. Tunny TJ, Klemm SA, Gordon RD. Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism. Clin Exp Pharmacol Physiol 17: 167-171, 1990.
3. Imai T, Seo H, Murata Y, et al. Dexamethasone-nonsuppressible cortisol in two cases with aldosterone-producing adenoma. J Clin Endocrinol Metab 72: 575-581, 1991.
4. Abe K. Diagnosis and treatment of secondary hypertension. Nippon Naika Gakkai Zasshi (J Jpn Soc Int Med) 83: 1606-1613, 1994.
5. Honda T, Nakamura T, Saito Y, Ohyama Y, Sumino H, Kurabayashi M. Combined primary aldosteronism and preclinical Cushing's syndrome. An unusual case presentation of adrenal adenoma. Hypertens Res 24: 723-726, 2001.
6. Nagae A, Murakami E, Hiwada K, Kubota O, Takada Y, Ohmori T. Primary aldosteronism with cortisol overproduction from bilateral multiple adrenal adenomas. Jpn J Med 30: 26-31, 1991.
7. Baert D, Nobels F, Van Crombrugge P. Combined Conn's and Cushing's syndrome. An unusual presentation of adrenal adenoma. Acta Clin Belg 50: 310-313, 1995.
8. Tanaka M, Izeki M, Miyazaki Y, et al. Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Intern Med 41: 967-971, 2002.
9. Conn JW, Knope RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107: 159-172, 1964.
10. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87: 4872-4878, 2002.
11. Matsumoto K, Miyake S, Yano M, et al. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care 22: 1191-1195, 1999.
12. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M. Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 26: 163-167, 2003.
13. Nawata H, Idemura H, Suda T, Takayanagi R. Annual Report of the Ministry of Health and Welfare "Disorders of adrenal hormones" Research Committee. 223-226, 1996 (in Japanese).
14. Makino S, Oda S, Saka T, Yasukawa M, Komatsu F, Sasano H. A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing's syndrome and hypersecretion of parathyroid hormone. Endocr J 48: 103-111, 2001.
15. Sugawara A, Takeuchi K, Suzuki T, Itoi K, Sasano H, Ito S. A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis. Histopathological analyses of the adrenal gland. Hypertens Res 26: 663-668, 2003.
16. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29: 498-502, 1980.
17. Fukudome Y, Fujii K, Arima H, et al. Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens Res 25: 11-18, 2002.
18. Bonora E, Moghetti P, Zancanaro, C, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68: 374-378, 1989.
19. Leahy LL. β-cell dysfunction in type 2 diabetes mellitus. in: Joslin's Diabetes Mellitus. 14th ed. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, Eds. Lippincott, Williams & Wilkins, Philadelphia, 2005: 449-461.
20. Shimamoto K, Shiiki M, Ise T, et al. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Human Hypertens 8: 755-759, 1994.